Viewing Study NCT00195312



Ignite Creation Date: 2024-05-05 @ 11:57 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00195312
Status: TERMINATED
Last Update Posted: 2007-12-05
First Post: 2005-08-05

Brief Title: Study Evaluating Vaccine in Adults With HIV
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization: Wyeth is now a wholly owned subsidiary of Pfizer

Study Overview

Official Title: A Phase 1 Multicenter Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine Administered Alone or With Escalating Doses of IL-12 DNA or IL-15 DNA Molecular Adjuvants to HIV-1 Positive Adults Receiving Stable HAART
Status: TERMINATED
Status Verified Date: 2007-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The main purpose of this study is to learn whether the study vaccine and the adjuvantsdrugs that are used to help immune response have an acceptable safety profile in treating individuals with HIV

A second purpose for this study is to understand how your immune system responds to the study vaccine with the adjuvants Understanding these differences could be useful in several ways First it might help identify people whose disease is likely to respond to the study vaccine with the study adjuvants Second the information might be useful in developing other treatments for people whose disease does not respond to the study vaccine with the adjuvants
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None